Publications (108)

2022

  1. Correction to: Bone loss induced by cancer treatments in breast and prostate cancer patients (Clinical and Translational Oncology, (2022), 24, 11, (2090-2106), 10.1007/s12094-022-02872-1)

    Clinical and Translational Oncology

  2. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  3. Clinical practice recommendations for the diagnosis and treatment of X-linked hypophosphatemia: A consensus based on the ADAPTE method

    Medicina Clinica, Vol. 159, Núm. 3, pp. 152.e1-152.e12

  4. Bone loss induced by cancer treatments in breast and prostate cancer patients

    Clinical and Translational Oncology, Vol. 24, Núm. 11, pp. 2090-2106

2021

  1. Trabecular bone score and bone mineral density in patients with long-term controlled acromegaly

    Clinical Endocrinology, Vol. 95, Núm. 1, pp. 58-64

  2. Adult height and long-term outcomes after rhIGF-1 therapy in two patients with PAPP-A2 deficiency

    Growth Hormone and IGF Research, Vol. 60-61

2020

  1. Hypophosphataemic Rickets: Similar Phenotype of Different Diseases

    Advances in Therapy, Vol. 37, pp. 80-88

  2. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy

    Cancer Medicine, Vol. 9, Núm. 16, pp. 5746-5755

  3. Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer

    Medical sciences (Basel, Switzerland), Vol. 8, Núm. 4

2019

  1. Different development of serum sclerostin compared to other bone remodeling markers in the first year after a liver transplant

    Revista de Osteoporosis y Metabolismo Mineral

  2. Enfermedad metabólica ósea postrasplante

    Anales de la Real Academia Nacional de Medicina, Núm. 136, pp. 249-255

2018

  1. Farmacología del calcio y del hueso

    Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 647-656

  2. Tratamiento de la osteoporosis: osteoporosis en la mujer premenopáusica y posmenopáusica. Osteoporosis en el varón

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 60, pp. 3506-3514

  3. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy

    Endocrine, Vol. 62, Núm. 1, pp. 166-173

  4. Identification of hypophosphatasia in a clinical setting: Clinical manifestations and diagnostic recommendations in adult patients

    Medicina Clinica, Vol. 150, Núm. 2, pp. 75-79

  5. Consensus document on osteoporosis in males

    Endocrinologia, Diabetes y Nutricion, Vol. 65, pp. 9-16

2017

  1. Thyroid hormones, TSH, thyroid cancer and bones in pre- and postmenopausal women

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 9, Núm. 2, pp. 89-101

2016

  1. Seven years of follow up of trabecular bone score, bone mineral density, body composition and quality of life in adults with growth hormone deficiency treated with rhGH replacement in a single center

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 7, Núm. 3, pp. 93-100

  2. Serum Levels of Osteocalcin and Insulin Resistance in Patients with Impaired Glucose Tolerance or New-Onset Diabetes Mellitus after Liver Transplantation

    Hormone and Metabolic Research, Vol. 48, Núm. 5, pp. 325-330

  3. Recalcitrant hypocalcaemia in a patient with post-thyroidectomy hypoparathyroidism and Roux-en-Y gastric bypass

    Obesity Research and Clinical Practice, Vol. 10, Núm. 3, pp. 344-347